Anzeige
❌
Mehr »
Mittwoch, 28.10.2026 - Börsentäglich über 12.000 News
Der nächste Bergbau-Boom, von dem noch niemand etwas weiß
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

OMX Iceland 15 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im OMX Iceland 15

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
18:15Brim Financial partners with Manulife Bank on credit cards3
17:45Festi hf.: Financial results for Q3 2026302Revenue growth and cost discipline amid challenging external conditions Q3 2026 Key Operating Results Sales of goods and services amounted to ISK 51,147 million, up 8.6% year-on-year.Margin from sales...
► Artikel lesen
17:35Arion Bank hf.: Q3 2026 results326Arion Bank's return on equity was 16.3% in the third quarter of 2026 and 15.1% for the first nine months of 2026. Investor meeting and webcast in English on 29 October at 9:30 CET (8:30 GMT). Financial...
► Artikel lesen
12:06Alvotech to Report Financial Results for the Nine-Month Period to September 30, 20268
DiArion Bank hf.: Arion Bank reaches settlement with the Financial Supervisory Authority213Arion Bank has reached a settlement with the Financial Supervisory Authority of the Central Bank of Iceland (the FSA). The settlement follows a review initiated by the FSA in April 2024 concerning the...
► Artikel lesen
MoKvika banki hf.: Transaction in relation to a share buy-back programme7
FrH.C. Wainwright reiterates Buy on Oculis stock, $39 target on biomarker data8
FrIcelandair Q3 2026 slides: record revenue, tough winter ahead9
DoIcelandair Group hf.: financial results Q3 2026242Record revenue of USD 655.0 million, up 12% year-on-yearEBIT of USD 120.3 million, improving by USD 45.9 million year-on-year, with the EBIT margin rising to 18.4% from 12.7%Profitability improved despite...
► Artikel lesen
DoOculis veröffentlicht Biomarker-Daten aus Phase-2-Studie bei Optikusneuritis8
DoOculis reports biomarker data from optic neuritis trial5
DoOculis Holding AG: Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor's Neuroprotective Potential in Optic Neuritis5